Patents by Inventor Wangni Tian

Wangni Tian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical used for treating HIV infection, the composition and uses thereof
    Patent number: 7335727
    Abstract: A fusion inhibitor used to treat HIV infection, has an amino acid sequence as follows: X-SWETWEREIENYTKQIYKILEESQEQQDRNEKDLLE-Z, wherein X is either an amino group or -X1-X2, wherein X1 is an imino group, and X2 is either an acetyl group, a hydrophobic group, or a macromolecular carrier group; Z is a carboxyl group or -Z1-Z2, wherein Z1 is a carbonyl group, and Z2 is either an amino group, a tert-butyloxycarbonyl group, a hydrophobic group, or a macromolecular carrier group. This inhibitor has strong inhibitory activity against HIV infection.
    Type: Grant
    Filed: November 3, 2005
    Date of Patent: February 26, 2008
    Assignee: Tianjin Fusogen Biotech Co., Ltd.
    Inventors: Genfa Zhou, Wangni Tian
  • Pharmaceutical used for treating HIV infection, the composition and uses thereof
    Publication number: 20060100139
    Abstract: A fusion inhibitor used to treat HIV infection, has an amino acid sequence as follows: X-SWETWEREIENYTKQIYKILEESQEQQDRNEKDLLE-Z, wherein X is either an amino group or -X1-X2, wherein X1 is an imino group, and X2 is either an acetyl group, a hydrophobic group, or a macromolecular carrier group; Z is a carboxyl group or -Z1-Z2, wherein Z1 is a carbonyl group, and Z2 is either an amino group, a tert-butyloxycarbonyl group, a hydrophobic group, or a macromolecular carrier group. This inhibitor has strong inhibitory activity against HIV infection.
    Type: Application
    Filed: November 3, 2005
    Publication date: May 11, 2006
    Inventors: Genfa Zhou, Wangni Tian
  • Pharmaceutical being used for treating HIV infection, the composition and uses thereof
    Patent number: 6962900
    Abstract: A pharmaceutical being used for treating HIV infection is provided which has the following peptide sequence: X-SWETWEREIENYTKQIYKILEESQQDRN-EKDRNEKDLLE-Z, where S is Serine, W is Trytophan, E is Glutamate, T is Threonine, R is Argine, I is Isoleucine, N is Asparagine, Y is Tyrosine, K is Lysine, Q is Glutamine, L is Leucine, D is Aspartic acid, X is amino group, acetyl-hydrophobic group, or macromolecule carrier group, Z is carboxyl group, amino group, amido group, tert-nutyloxycarbonyl group, hydrophobic group, or macromolecule carrier group. The drug inhibits strongly the infection of HIV.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: November 8, 2005
    Assignee: Tianjin Fusogen Biotech Co., Ltd.
    Inventors: Genfa Zhou, Wangni Tian
  • Pharmaceutical being used for treating hiv infection, the composition and uses thereof
    Publication number: 20040248789
    Abstract: A pharmaceutical being used for treating HIV infection is provided which has the following peptide sequence: X-SWETWEREIENYTKQIYKILEESQQDRN-EKDRNEKDLLE-Z, where S is Serine, W is Trytophan, E is Glutamate, T is Threonine, R is Argine, I is Isoleucine, N is Asparagine, Y is Tyrosine, K is Lysine, Q is Glutamine, L is Leucine, D is Aspartic acid, X is amino group, acetyl-hydrophobic group, or macromolecule carrier group, Z is carboxyl group, amino group, amido group, tert-nutyloxycarbonyl group, hydrophobic group, or macromolecule carrier group. The drug inhibits strongly the infection of HIV.
    Type: Application
    Filed: July 19, 2004
    Publication date: December 9, 2004
    Inventors: Genfa Zhou, Wangni Tian